Problem

Framewise Health addresses the persistent failure of conventional patient education: complex, generic paper packets are difficult to understand and act on, especially when health literacy is low. The company cites that nearly nine in ten U.S. adults lack proficient health literacy, linking ineffective learning to poor adherence and outcomes; it also points to more than $500 billion in annual preventable medication-related harm. The clearest “killer” use case is hospital discharge, when patients must understand medications, restrictions, warning signs, and recovery steps before they go home, yet care teams have limited time to ensure comprehension.

The operational pain is both clinical and economic. Hospitals and specialty practices must repeatedly explain the same instructions, chase patients who are confused or nonadherent, and absorb the downstream costs of avoidable complications and readmissions. Framewise’s value proposition is therefore to make discharge education more understandable and measurable while reducing the staff effort required to support recovery.

Product / Service

Framewise converts a patient’s medical record, institutional protocols, and national drug information into a personalized recovery or education video. Its website describes an integration model that pulls diagnosis, medications, allergies, language, and discharge-plan data from an EHR through FHIR, supports major systems and any FHIR R4 endpoint, and uses clinician review alongside AI personalization. Videos are delivered by SMS before the patient leaves, in 75-plus languages, without requiring an app or login.

The product is designed as a B2B patient-engagement layer for hospitals, specialty groups, pharma, medical-device companies, and private clinics. Beyond delivering instructions, it records what each patient understood by topic and feeds that comprehension data back to the care team, allowing staff to identify patients who need a callback. The intended benefits are better accessibility and adherence, less manual follow-up, and potentially fewer complications and readmissions.

Market

Framewise competes in digital patient education, patient engagement, and healthcare workflow software, with a particularly focused wedge in personalized discharge and recovery instructions. Its competitive set includes established education and engagement platforms such as Healthwise, now part of WebMD’s patient-engagement offering, Wolters Kluwer’s UpToDate Patient Education, and Get Well/GW RhythmX, as well as adjacent EHR-native communication tools such as Epic. Framewise differentiates itself through patient-specific video generation, multilingual SMS delivery, clinician review, FHIR interoperability, and a feedback loop based on comprehension data.

As of August 1, 2026, the company appears to be an exceptionally early-stage venture rather than a business with publicly demonstrated scale. Y Combinator lists it as an active Spring 2026 company founded by a two-person team, while PitchBook reports a $500,000 accelerator/incubator deal and labels the financing stage “Generating Revenue.” However, no revenue amount, customer count, customer logos, pilots, or usage metrics were publicly disclosed in the researched materials, so its commercial traction and whether revenue is recurring or material remain unverified; “pre-revenue” cannot be confirmed, but the public evidence supports an early commercialization characterization.